Chemo: IV vs. Pills, A Matter of Cost in Your State
Chemo: IV vs. Pills, A Matter of Cost in Your State
Michelle Andrews of Kaiser Health News talks about health insurance companies’ coverage of chemotherapy. Watch the clip here.
News
Ovarian Cancer Cell Stiffness Can Indicate Metastatic Poten...
Ovarian Cancer Cell Stiffness Can Indicate Metastatic Potential
A new study indicates that the stiffness of an ovarian cancer cell can indicate whether or not it is likely to be metastatic: the more stiff the cell is, the more likely it is to be malignant. The abstract is here An article on the study is here
OCRF Talks Q&A with Ruprecht Wiedemeyer, Ph.D.
OCRF Talks Q&A with Ruprecht Wiedemeyer, Ph.D.
Dr. Ruprecht Wiedemeyer is a 2012 Liz Tilberis Grantee. In this interview with OCRF's Sarah DeFeo, Dr. Wiedemeyer discusses his research and what it means to receive a grant from OCRF.
Q&A with Kate Lawrenson, Ph.D.
Q&A with Kate Lawrenson, Ph.D.
Dr. Kate Lawrenson is a 2012 Ann Schreiber Program of Excellence Grantee. In this interview with OCRF's Sarah DeFeo, Dr. Lawrenson discusses her research and what it means to receive a grant from OCRF.
Q&A with Melinda Yates, Ph.D.
Q&A with Melinda Yates, Ph.D.
Dr. Melinda Yates is a 2012 Ann Schreiber Program of Excellence Grantee. In this interview with OCRF's Sarah DeFeo, Dr. Yates discusses her research and what it means to receive a grant from OCRF.
Q&A with Karen Cowden Dahl, PhD
Q&A with Karen Cowden Dahl, PhD
Dr. Karen Cowden Dahl is a 2012 Liz Tilberis Grant Recipient. In this interview with OCRF's Sarah DeFeo, Dr. Cowden Dahl discusses her research and what it means to receive a grant from OCRF.
Q&A with Selvendiran Karuppaiyah, PhD
Q&A with Selvendiran Karuppaiyah, PhD
Dr. Selvendiran Karuppaiyah is a 2011 Liz Tilberis Grant Recipient. In this interview with OCRF's Sarah DeFeo, Dr. Karuppaiyah discusses his research and what it means to receive a grant from OCRF.
OCRF Talks Q & A with Joanna Burdette, PhD.
OCRF Talks Q & A with Joanna Burdette, PhD.
Dr. Joanna Burdette is a 2011 Liz Tilberis Grant Recipient. In this interview with OCRF's Sarah DeFeo, Dr. Burdette discusses her research and what it means to receive a grant from OCRF.
Q&A with Tsz-Lun Yeung, Ph.D.
Q&A with Tsz-Lun Yeung, Ph.D.
Dr. Tsz-Lun Yeung, Ph.D. is a 2011 Ann Schreiber Program of Excellence Grant Recipient.
Q&A with Sarah Adams, M.D., 2011 Liz Tilberis Awardee
Dr. Sarah Adams is a 2011 Liz Tilberis Grant Recipient.
Q&A with Gregory Motz, PhD.
Q&A with Gregory Motz, PhD.
Dr. Gregory Motz is a 2011 Ann Schreiber Program of Excellence Grantee. In this interview with OCRF's Sarah DeFeo, Dr. Motz discusses his research, what motivated him to focus his efforts on ovarian cancer research, and what it means to receive a grant from OCRF.
Q&A with Ruth Perets, M.D., Ph.D., Dana Farber Cancer ...
Q&A with Ruth Perets, M.D., Ph.D., Dana Farber Cancer Institute
Dr. Ruth Perets is a 2011 Ann Schreiber Program of Excellence Grant Recipient. Her research is funded in part thanks to the support of The National Ovarian Cancer Coalition.